KRYS
Krystal Biotech Inc
Price:  
187.15 
USD
Volume:  
328,146.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KRYS WACC - Weighted Average Cost of Capital

The WACC of Krystal Biotech Inc (KRYS) is 7.4%.

The Cost of Equity of Krystal Biotech Inc (KRYS) is 11.05%.
The Cost of Debt of Krystal Biotech Inc (KRYS) is 5.00%.

Range Selected
Cost of equity 7.50% - 14.60% 11.05%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.6% - 9.1% 7.4%
WACC

KRYS WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.8 1.73
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 14.60%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 5.6% 9.1%
Selected WACC 7.4%